BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36315002)

  • 1. Too Much Fuel on the Fire? Linking Obesity, Metabolism, and Melanoma Outcomes.
    Smalley KSM
    Clin Cancer Res; 2023 Jan; 29(1):5-7. PubMed ID: 36315002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.
    Hahn AW; Menk AV; Rivadeneira DB; Augustin RC; Xu M; Li J; Wu X; Mishra AK; Gide TN; Quek C; Zang Y; Spencer CN; Menzies AM; Daniel CR; Hudgens CW; Nowicki T; Haydu LE; Khan MAW; Gopalakrishnan V; Burton EM; Malke J; Simon JM; Bernatchez C; Putluri N; Woodman SE; Vashisht Gopal YN; Guerrieri R; Fischer GM; Wang J; Wani KM; Thompson JF; Lee JE; Hwu P; Ajami N; Gershenwald JE; Long GV; Scolyer RA; Tetzlaff MT; Lazar AJ; Schadendorf D; Wargo JA; Kirkwood JM; DeBerardinis RJ; Liang H; Futreal A; Zhang J; Wilmott JS; Peng W; Davies MA; Delgoffe GM; Najjar YG; McQuade JL
    Clin Cancer Res; 2023 Jan; 29(1):154-164. PubMed ID: 36166093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIL in Melanoma-Similar Approaches, Different Results, Unanswered Questions.
    Sznol M
    Clin Cancer Res; 2021 Oct; 27(19):5156-5157. PubMed ID: 34413160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Melanoma microenvironment-impact of modern therapies].
    Sirokay J; Mauch C
    Dermatologie (Heidelb); 2022 Dec; 73(12):907-914. PubMed ID: 36394589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition.
    Naik GS; Waikar SS; Johnson AEW; Buchbinder EI; Haq R; Hodi FS; Schoenfeld JD; Ott PA
    J Immunother Cancer; 2019 Mar; 7(1):89. PubMed ID: 30922394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome.
    Warner AB; McQuade JL
    Curr Oncol Rep; 2019 Jul; 21(8):72. PubMed ID: 31263961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study.
    Lee JH; Hyung S; Lee J; Choi SH
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies.
    Gibson TM; Park Y; Robien K; Shiels MS; Black A; Sampson JN; Purdue MP; Freeman LE; Andreotti G; Weinstein SJ; Albanes D; Fraumeni JF; Curtis RE; Berrington de Gonzalez A; Morton LM
    J Clin Oncol; 2014 Dec; 32(35):4004-11. PubMed ID: 25267739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma.
    Di Guardo L; Randon G; Corti F; Vallacchi V; Raimondi A; FucĂ  G; Bini M; Maurichi A; Patuzzo R; Gallino G; Mattavelli I; Ruggeri R; Angi M; Cossa M; Valeri B; Cimminiello C; Santinami M; Rivoltini L; de Braud F; Rodolfo M; Vecchio MD
    Oncologist; 2021 Dec; 26(12):1079-1084. PubMed ID: 34355463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity induced rapid melanoma progression is reversed by orlistat treatment and dietary intervention: role of adipokines.
    Malvi P; Chaube B; Pandey V; Vijayakumar MV; Boreddy PR; Mohammad N; Singh SV; Bhat MK
    Mol Oncol; 2015 Mar; 9(3):689-703. PubMed ID: 25499031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
    McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K
    Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of total metabolic tumour volume and therapy-response assessment by [
    Annovazzi A; Ferraresi V; Rea S; Russillo M; Renna D; Carpano S; Sciuto R
    Eur Radiol; 2022 May; 32(5):3398-3407. PubMed ID: 34779873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
    Forget MA; Haymaker C; Hess KR; Meng YJ; Creasy C; Karpinets T; Fulbright OJ; Roszik J; Woodman SE; Kim YU; Sakellariou-Thompson D; Bhatta A; Wahl A; Flores E; Thorsen ST; Tavera RJ; Ramachandran R; Gonzalez AM; Toth CL; Wardell S; Mansaray R; Patel V; Carpio DJ; Vaughn C; Farinas CM; Velasquez PG; Hwu WJ; Patel SP; Davies MA; Diab A; Glitza IC; Tawbi H; Wong MK; Cain S; Ross MI; Lee JE; Gershenwald JE; Lucci A; Royal R; Cormier JN; Wargo JA; Radvanyi LG; Torres-Cabala CA; Beroukhim R; Hwu P; Amaria RN; Bernatchez C
    Clin Cancer Res; 2018 Sep; 24(18):4416-4428. PubMed ID: 29848573
    [No Abstract]   [Full Text] [Related]  

  • 15. The Treatment of Advanced Melanoma: Therapeutic Update.
    Villani A; Potestio L; Fabbrocini G; Troncone G; Malapelle U; Scalvenzi M
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
    Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival.
    Vallet A; Oriano B; Mortier L; Dalle S; Dutriaux C; Guillot B; Leccia MT; Dalac S; Saiag P; Lacour JP; Legoupil D; De Quatrebarbes J; Brunet-Possenti F; Lesimple T; Arnault JP; Aubin F; Granel-Brocard F; Stoebner PE; Maubec E; Dreno B; Allayous C; Porcher R; Lebbé C;
    JAMA Dermatol; 2019 Jun; 155(6):673-678. PubMed ID: 31042256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Obesity on Surgically Treated Locoregional Melanoma.
    Harrell Shreckengost CS; Tariq M; Farley CR; Zhang C; Delman KA; Kudchadkar RR; Lowe MC
    Ann Surg Oncol; 2021 Oct; 28(11):6140-6151. PubMed ID: 33718977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges.
    Millet A; Martin AR; Ronco C; Rocchi S; Benhida R
    Med Res Rev; 2017 Jan; 37(1):98-148. PubMed ID: 27569556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human embryos from overweight and obese women display phenotypic and metabolic abnormalities.
    Leary C; Leese HJ; Sturmey RG
    Hum Reprod; 2015 Jan; 30(1):122-32. PubMed ID: 25391239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.